REQUEST A DEMO
Total
USD $0.00
Search more companies

Adt Biotech Sdn. Bhd. (Malaysia)

Main Activities: Marketing Research and Public Opinion Polling | Other Services (except Public Administration)
Full name: Adt Biotech Sdn. Bhd. Profile Updated: August 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Adt Biotech Sdn. Bhd operates in the molecular diagnostics industry. The company develops and commercializes in vitro diagnostic products for the healthcare markets in the Asia Pacific region. Their portfolio includes shrimp disease detection kits, syndromic disease panels, and real-time PCR detection kits for infectious diseases, genetic and oncogenic markers. Adt Biotech Sdn. Bhd has achieved BioNexus Status and has a subsidiary in India. Their latest contribution is the LyteStar 2019 - nCoV RT - PCR kit for the detection of SARS - CoV-2. The company aims to provide faster and more accurate diagnostic tests and technologies to support healthcare practitioners in making better treatment and patient management decisions.

Headquarters
Unit No.307,Block B, Pusat Dagangan Phileo Damansara I, No.9,Jalan 16/11
Petaling Jaya; Selangor; Postal Code: 46350

Contact Details: Purchase the Adt Biotech Sdn. Bhd. report to view the information.

Website: http://www.adt-biotech.com

Basic Information
Outstanding Shares:
Purchase the Adt Biotech Sdn. Bhd. report to view the information.
Registered Capital:
Purchase the Adt Biotech Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Adt Biotech Sdn. Bhd. report to view the information.
Incorporation Date:
November 11, 2009
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Adt Biotech Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
-57.57%
Total operating revenue
-57.57%
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
N/A
Total assets
-9.65%
Total equity
-8.83%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?